Literature DB >> 30173740

Multi-drug resistant Escherichia coli in diarrhoeagenic foals: Pulsotyping, phylotyping, serotyping, antibiotic resistance and virulence profiling.

C A Kennedy1, C Walsh2, M Karczmarczyk3, S O'Brien3, N Akasheh4, M Quirke5, S Farrell-Ward3, T Buckley6, U Fogherty6, K Kavanagh6, C T Parker7, T Sweeney1, S Fanning8.   

Abstract

Extraintestinal pathogenic E. coli (ExPEC) possess the ability to cause extraintestinal infections such as urinary tract infections, neonatal meningitis and sepsis. While information is readily available describing pathogenic E. coli populations in food-producing animals, studies in companion/sports animals such as horses are limited. In addition, many antimicrobial agents used in the treatment of equine infections are also utilised in human medicine, potentially contributing to the spread of antibiotic resistance determinants among pathogenic strains. The aim of this study was to phenotypically and genotypically characterise the multidrug resistance and virulence associated with 83 equine E. coli isolates recovered from foals with diarrhoeal disease. Serotyping was performed by both PCR and sequencing. Antibiotic resistance was assessed by disc diffusion. Phylogenetic groups, virulence genes, antibiotic resistance genes and integrons were determined by PCR. Thirty-nine (46%) of the isolates were classified as ExPEC and hence considered to be potentially pathogenic to humans and animals. Identified serogroups O1, O19a, O40, O101 and O153 are among previously reported human clinical ExPEC isolates. Over a quarter of the E. coli were assigned to pathogenic phylogroups B2 (6%) and D (23%). Class 1 and class 2 integrons were detected in 85% of E. coli, revealing their potential to transfer MDR to other pathogenic and non-pathogenic bacteria. With 65% of potentially pathogenic isolates harbouring one or more TEM, SHV and CTX-M-2 group β-lactamases, in addition to the high levels of resistance to fluoroquinolones observed, our findings signal the need for increased attention to companion/sport animal reservoirs as public health threats.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adherence and invasion PFGE; Antibiotic resistance; Diarrhoeagenic; ESBL; Escherichia coli; ExPEC; Foals; Serotyping

Mesh:

Substances:

Year:  2018        PMID: 30173740     DOI: 10.1016/j.vetmic.2018.08.009

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  4 in total

1.  Diarrhea-Causing Bacteria and Their Antibiotic Resistance Patterns Among Diarrhea Patients From Ghana.

Authors:  Theophilus Afum; Diana Asema Asandem; Prince Asare; Adwoa Asante-Poku; Gloria Ivy Mensah; Abdul Basit Musah; David Opare; Kiyosi Taniguchi; Nuhu Muniru Guinko; Thelma Aphour; Doris Arhin; Koichi Ishikawa; Tetsuro Matano; Taketoshi Mizutani; Franklin Asiedu-Bekoe; Hiroshi Kiyono; Abraham Kwabena Anang; Kwadwo Ansah Koram; Dorothy Yeboah-Manu
Journal:  Front Microbiol       Date:  2022-05-19       Impact factor: 6.064

2.  Genomic Characterization of Escherichia coli Isolates Belonging to a New Hybrid aEPEC/ExPEC Pathotype O153:H10-A-ST10 eae-beta1 Occurred in Meat, Poultry, Wildlife and Human Diarrheagenic Samples.

Authors:  Dafne Díaz-Jiménez; Isidro García-Meniño; Alexandra Herrera; Vanesa García; Ana María López-Beceiro; María Pilar Alonso; Jorge Blanco; Azucena Mora
Journal:  Antibiotics (Basel)       Date:  2020-04-17

3.  Molecular characterization and antimicrobial resistance of potentially human-pathogenic Escherichia coli strains isolated from riding horses.

Authors:  Pouya Reshadi; Fatemeh Heydari; Reza Ghanbarpour; Mahboube Bagheri; Maziar Jajarmi; Mohadese Amiri; Hesam Alizade; Mahdi Askari Badouei; Shademan Sahraei; Nasrin Adib
Journal:  BMC Vet Res       Date:  2021-03-25       Impact factor: 2.741

4.  Escherichia coli Causing Neonatal Meningitis During 2001-2020: A Study in Eastern China.

Authors:  Yanli Liu; Minli Zhu; Xiaoqin Fu; Jiaojiao Cai; Shangqin Chen; Yuanyuan Lin; Na Jiang; Si Chen; Zhenlang Lin
Journal:  Int J Gen Med       Date:  2021-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.